After Reaching Milestone, Is Inmune Bio Inc (NASDAQ:INMB)’s Short Interest Revealing Something?

The stock of Inmune Bio Inc (NASDAQ:INMB) registered a decrease of 16.52% in short interest. INMB’s total short interest was 9,600 shares in September as published by FINRA. Its down 16.52% from 11,500 shares, reported previously. With 18,700 shares average volume, it will take short sellers 1 days to cover their INMB’s short positions. The short interest to Inmune Bio Inc’s float is 0.46%.

The stock decreased 1.62% or $0.1 during the last trading session, reaching $6.09. About 10,709 shares traded. INmune Bio Inc. (NASDAQ:INMB) has 0.00% since September 13, 2018 and is . It has by 0.00% the S&P500.

INmune Bio Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer. The company has market cap of $65.44 million. The firm intends to develop and commercialize product candidates to treat diseases comprising hematologic malignancies and solid tumors. It currently has negative earnings. The Company’s development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma; INB03 that treats patients with advanced cancers with elevated biomarkers of inflammation, including elevated levels of myeloid derived suppressor cells in their blood; and XPro1595 for the treatment of Alzheimer's disease.

More notable recent INmune Bio Inc. (NASDAQ:INMB) news were published by: Seekingalpha.com which released: “Piper softens view on Jazz Pharma in premarket analyst action – Seeking Alpha” on August 21, 2019, also Globenewswire.com with their article: “INmune Bio Announces Publication of Data on INKmune Primed NK cells in Peer-Reviewed Journal PLOS ONE – GlobeNewswire” published on June 27, 2019, Globenewswire.com published: “INmune Bio Inc. Featured in Exclusive NetworkNewsWire Broadcast – GlobeNewswire” on June 11, 2019. More interesting news about INmune Bio Inc. (NASDAQ:INMB) were released by: Finance.Yahoo.com and their article: “Do Insiders Own Lots Of Shares In INmune Bio Inc. (NASDAQ:INMB)? – Yahoo Finance” published on May 07, 2019 as well as Benzinga.com‘s news article titled: “38 Stocks Moving In Wednesday’s Mid-Day Session – Benzinga” with publication date: August 28, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.